Pralea, I.-E.; Moldovan, R.-C.; Èšigu, A.-B.; Moldovan, C.-S.; Fischer-Fodor, E.; Iuga, C.-A.
Cellular Responses Induced by NCT-503 Treatment on Triple-Negative Breast Cancer Cell Lines: A Proteomics Approach. Biomedicines 2024, 12, 1087.
https://doi.org/10.3390/biomedicines12051087
AMA Style
Pralea I-E, Moldovan R-C, Èšigu A-B, Moldovan C-S, Fischer-Fodor E, Iuga C-A.
Cellular Responses Induced by NCT-503 Treatment on Triple-Negative Breast Cancer Cell Lines: A Proteomics Approach. Biomedicines. 2024; 12(5):1087.
https://doi.org/10.3390/biomedicines12051087
Chicago/Turabian Style
Pralea, Ioana-Ecaterina, Radu-Cristian Moldovan, Adrian-Bogdan Èšigu, Cristian-Silviu Moldovan, Eva Fischer-Fodor, and Cristina-Adela Iuga.
2024. "Cellular Responses Induced by NCT-503 Treatment on Triple-Negative Breast Cancer Cell Lines: A Proteomics Approach" Biomedicines 12, no. 5: 1087.
https://doi.org/10.3390/biomedicines12051087
APA Style
Pralea, I.-E., Moldovan, R.-C., Èšigu, A.-B., Moldovan, C.-S., Fischer-Fodor, E., & Iuga, C.-A.
(2024). Cellular Responses Induced by NCT-503 Treatment on Triple-Negative Breast Cancer Cell Lines: A Proteomics Approach. Biomedicines, 12(5), 1087.
https://doi.org/10.3390/biomedicines12051087